Related Experiment Video
Updated: Jan 16, 2026

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing
Published on: August 25, 2018
What Stage Are We at in the Development of Vaccines Against Tick-Borne Diseases?
Weronika Stachera1, Magdalena Szuba1, Arya Taesung Kim1
1Department of General Biology and Parasitology, Medical University of Warsaw, 02-004 Warsaw, Poland.
Abstract:
The increasing prevalence of Lyme disease, tick-borne encephalitis (TBE), and other tick-borne infections such as Babesia, Ehrlichia, Rickettsia, and Anaplasma is a growing public health concern. Existing tick bite prevention strategies are insufficient; therefore, vaccines represent a promising preventive measure. At the moment, only a vaccine for tick-borne encephalitis is available on the market. A vaccine for Lyme disease, however, is at an advanced stage of clinical trials. In this article, we focus on describing the progress in the invention of vaccines for tick-borne diseases. This article analyzes their development and effectiveness.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Preclinical Development: Overview

